Medical technology pioneer AstraZeneca has chosen the Cambridge Biomedical Campus at the Addenbrooke’s Hospital site in Cambridge UK for its new global headquarters.
It will make a formal announcement in June. The Biomedical Campus has been chosen over Granta Park where AZ’s biologics division MedImmune has massively grown its presence. None of the parties involved are making any comment. The decision is a major boost for the Biomedical Campus where The Queen today officially opened the MRC’s Laboratory of Molecular Biology.